IP Library Granted Patent US 8,206,721
Granted Patent B2
US 8,206,721 · App. 12/760,173 · Granted Jun 26, 2012

Use of an extract from snow algae in cosmetic or dermatological formulations

Assignee: Mibelle AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,206,721
App. No.
12/760,173
Granted
Jun 26, 2012
Kind
B2
Abstract

The present invention relates to the use of an extract from snow algae, especially an extract from Chlamydocapsa sp (snow algae) in cosmetic and/or pharmaceutical products. More particularly, the invention relates to Chlamydocapsa sp. (snow algae) in cosmetic and/or pharmaceutical products employed to guard against extrinsic aging of the skin caused by negative environmental exposure, for instance, UV radiation or air pollution, but also to guard against intrinsic aging of the skin as influenced by aging-specific gene expression levels. The invention relates furthermore to a method for producing extracts from snow algae, suitable for topic applications.

Claims (13)

1. A method for delaying skin aging comprising applying to the skin of a subject in need thereof a product comprising an effective amount of lysed Chlamydocapsa sp CCryo 101-99 snow algae.

2. A method for protecting skin against the loss of the barrier function induced by environmental exposure, comprising applying to the skin of a subject in need thereof a cosmetic composition comprising an effective amount of a snow algae extract wherein the snow algae extract is homogenized Chlamydocapsa sp Ccryo 101-99 snow algae.

3. The method according to claim 1 , wherein a Klotho anti-aging gene is activated.

4. The method according to claim 1 , wherein genes for collagen production are activated.

5. The method according to claim 1 , wherein gene expression of matrix metalloproteinases is reduced.

6. The method according to claim 2 , wherein transepidermal water loss (TEWL) after environmental exposure to ultraviolet (UV) radiation, cold or dryness is reduced.

7. The method according to claim 2 , wherein wrinkling of the skin induced by environmental exposure to ultraviolet radiation, cold or dryness is reduced.

8. The method according to claim 1 , wherein the Chlamydocapsa sp Ccryo 101-99snow algae has been induced to transform from the vegetative green phase into the stationary red phase prior to lysis.

9. The method according to claim 1 , wherein the lysed Chlamydocapsa sp CCryo 101-99 snow algae comprises from 0.01% to 10% of the product.

10. The method according to claim 1 , wherein the lysed Chlamydocapsa sp CCryo 101-99 snow algae is encapsulated in liposomes.

11. The method according to claim 1 , wherein the lysed Chlamydocapsa sp CCryo 101-99 snow algae is encapsulated in nanoemulsions.

12. The method according to claim 11 , wherein the nanoemulsions are dried to a powder on a matrix material.

13. The method according to claim 12 , wherein the matrix material comprises isomalt and polyvinlpyrrolidone.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2026
From: MIBELLE AG
To: SOLABIA BIOCHEMISTRY AG
Reel/Frame 074794/0435 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2010
From: STUTZ, CORNELIA SCHURCH, DR.; SCHMID, DANIEL, DR.; ZULLI, FRED, DR.
To: MIBELLE AG
Reel/Frame 024232/0314 →
Priority Claims (1)
CH 0917/09 · Jun 12, 2009 · national
Continuity (1)
Related Publication 20100316720A1 · Dec 16, 2010